EMV
EMVISION FPO [EMV]
Healthcare · ASX Small Cap
$1.7550 -0.6%
Updated 2026-03-02 · Scores refresh every scan
Appeared in 2 consecutive scans→ Score +4First seen: 2026-02-25
Score Breakdown
Technical41
Catalyst50
Sentiment50
Fundamental70
Momentum46
Risk Gate50
Active Signals
Bullish Signals
- RSI approaching oversold
- Near support level (potential bounce)
- Adequate cash runway (8 quarters)
- 4C filed 2026-01-27
- Moderate revenue growth (+11%)
- EPS estimates revised upward (+6pts)
- Near 52-week low (16% of range)
- ASX200 bullish (+1.5% 5d)
- RBA cutting (+2pts)
Risk Signals
- MACD momentum weakening
- Price below MAs (downtrend)
- Below 200-day MA (long-term downtrend)
- Deeply negative margins (-188%)
- Insufficient sentiment data (defaulting to neutral)
- Neutral/mixed sentiment
Recent Catalysts
NONE Half Yearly Presentation
NONE Half Yearly Report and Accounts
NONE Notification regarding unquoted securities - EMV
LOW Quarterly Activities/Appendix 4C Cash Flow Report
MEDIUM Strong emu Clinical Trial & Program Progress
Recent ASX Announcements
| 2026-02-22 | Half Yearly Presentation |
| 2026-02-22 | Half Yearly Report and Accounts PRICE SENSITIVE |
| 2026-02-06 | Notification regarding unquoted securities - EMV |
| 2026-01-27 | Quarterly Activities/Appendix 4C Cash Flow Report PRICE SENSITIVE |
| 2026-01-26 | Strong emu Clinical Trial & Program Progress PRICE SENSITIVE |
Key Metrics
$163.1M
Market Cap
26K
Avg Volume
1.5x
Vol Ratio
$1.63 — $2.43
52-Week Range
N/A
Short Interest
8 qtrs
Cash Runway
-58.0%
ROE
-188.0%
Profit Margin
CANSLIM Analysis
| Factor | Rating | Detail | |
|---|---|---|---|
| C | Current EPS | fail | EPS Growth: 0% |
| A | Annual Earnings | fail | CAGR: 0% |
| N | New Highs / Catalysts | neutral | |
| S | Supply & Demand | neutral | Float: 67% |
| L | Leader vs Laggard | laggard | RS: -1 |
| I | Institutional Sponsorship | weak | Inst: 3% |
| M | Market Direction | pass | Bullish |
Sector: Healthcare
Ranked #40 of 119 · Sector avg: 51
View all Healthcare signals →